ZMapp, once touted as a miraculous "secret serum" against the deadly Ebola virus, has shown some success but fell short of the bar for effectiveness in a clinical trial, researchers said Wednesday.
AFP
The News You Need, Delivered To You.
Subscribe to the Guardian today and never miss the stories that shape your Business